{"id":17990,"date":"2014-05-14T04:30:00","date_gmt":"2014-05-14T02:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/cina-tangenti-per-farmaci-sotto-accusa-manager-glaxo-2\/"},"modified":"2014-05-14T04:30:00","modified_gmt":"2014-05-14T02:30:00","slug":"cina-tangenti-per-farmaci-sotto-accusa-manager-glaxo-2","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/cina-tangenti-per-farmaci-sotto-accusa-manager-glaxo-2\/","title":{"rendered":"China: bribes for drugs, Glaxo manager accused"},"content":{"rendered":"<p style=\"text-align: left;\">&nbsp;<span style=\"color: rgb(34, 34, 34); font-family: Arial, sans-serif; font-size: 14pt;\">Beijing, May 14. \u2013 Chinese police have charged 46 people over bribes worth hundreds of millions of euros that British pharmaceutical company GlaxoSmithKline (GSK) allegedly paid Chinese doctors and hospitals to get them to prescribe their medicines to patients. It is the result of ten months of investigators in Changsha, the capital of Hunan province. According to reports by the Xinhua agency, among the accused is Mark Reilly, who has headed the Chinese division of the pharmaceutical group since 2009.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-bottom: 7.5pt; line-height: 13.5pt; text-align: left;\"><i><span style=\"font-size: 10pt; font-family: Arial, sans-serif; color: rgb(34, 34, 34); background-position: initial initial; background-repeat: initial initial;\">May 14, 2014<\/span><\/i><span style=\"font-size: 10pt; font-family: Arial, sans-serif; color: rgb(34, 34, 34); background-position: initial initial; background-repeat: initial initial;\"><span style=\"word-spacing: -0.55px;\"> \u2013 La Repubblica.it | 24 hours<\/span><span style=\"font-size: 12pt;\"><\/p>\n<p><\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left;\"><span style=\"font-size:8.0pt;line-height:107%;font-family: &quot;Starliner BTN&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:PMingLiU;mso-bidi-font-family: KodchiangUPC\">&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left;\"><span style=\"font-size:9.0pt;line-height:107%;font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;mso-fareast-font-family:PMingLiU\">&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left;\"><i><span style=\"font-size:9.0pt;line-height:107%;font-family: &quot;Helvetica&quot;,&quot;sans-serif&quot;;color:#C00000\">&nbsp;<\/span><\/i><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left;\"><span style=\"font-size:8.0pt; line-height:107%;font-family:&quot;Starliner BTN&quot;,&quot;sans-serif&quot;;mso-fareast-font-family: PMingLiU;mso-bidi-font-family:KodchiangUPC\">TO&nbsp;<\/p>\n<p><\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>&nbsp;Pechino, 14 mag. &#8211; La polizia cinese ha messo sotto accusa 46 persone per le tangenti da centinaia di milioni di euro che la casa farmaceutica britannica GlaxoSmithKline (GSK) avrebbe pagato a medici e strutture ospedaliere cinesi per convincerli a prescrivere ai pazienti i propri farmaci. E&#8217; il risultato dei dieci mesi degli investigatori di &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-17990","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17990","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=17990"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17990\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=17990"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=17990"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=17990"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}